Robust Th1 and Th17 immunity supports pulmonary clearance but cannot prevent systemic dissemination of highly virulent Cryptococcus neoformans H99

American Journal of Pathology

Volumn 175, Issue 6, 2009, Pages 2489-2500

  Zhang, Yanmei ^a,b   Wang, Fuyuan ^a,b   Tompkins, Kristin C ^a   McNamara, Andrew ^a   Jain, Aditya V ^a   Moore, Bethany B ^b,c   Toews, Galen B ^a,b   Huffnagle, Gary B ^b,c   Olszewski, Michal A ^a,b  

^a Ann Arbor Veterans Administration Health System 11R   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CELL POLARITY; CELLULAR IMMUNITY; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; ENCEPHALITIS; FUNGAL STRAIN; FUNGAL VIRULENCE; GENE DELETION; GENE EXPRESSION; GOBLET CELL; IMMUNOGLOBULIN BLOOD LEVEL; INOCULATION; KNOCKOUT MOUSE; LOEFFLER PNEUMONIA; LUNG ALVEOLUS MACROPHAGE; LUNG CLEARANCE; MACROPHAGE ACTIVATION; MENINGITIS; MENINGOENCEPHALITIS; MOUSE; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TH1 CELL; TH17 CELL; TH2 CELL;

EID: 73549089697     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.090530     Document Type: Article

References (47)

1. Kovacs JA, Kovacs AA, Polis M, Wright WC, Gill VJ, Tuazon CU, Gelmann EP, Lane HC, Longfield R, Overturf G, Macher AM, Fauci AS, Parrillo JE, Bennett JE, Masur H: Cryptococcosis in the acquired immunodeficiency syndrome. Ann Intern Med 1985, 103:533-538
2. Pappas PG, Perfect JR, Cloud GA, Larsen RA, Pankey GA, Lancaster DJ, Henderson H, Kauffman CA, Haas DW, Saccente M, Hamill RJ, Holloway MS, Warren RM, Dismukes WE: Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis 2001, 33:690-699
3. Baddley JW, Perfect JR, Oster RA, Larsen RA, Pankey GA, Henderson H, Haas DW, Kauffman CA, Patel R, Zaas AK, Pappas PG: Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated disease. Eur J Clin Microbiol Infect Dis 2008, 27:937-943
4. Hoang LM, Maguire JA, Doyle P, Fyfe M, Roscoe DL: Cryptococcus neoformans infections at Vancouver Hospital and Health Sciences Centre (1997-2002): epidemiology, microbiology and histopathology. J Med Microbiol 2004, 53:935-940
5. Zahra LV, Azzopardi CM, Scott G: Cryptococcal meningitis in two apparently immunocompetent Maltese patients. Mycoses 2004, 47:168-173
6. Hofman V, Venissac N, Mouroux C, Butori C, Mouroux J, Hofman P: Disseminated pulmonary infection due to Cryptococcus neoformans in a non immunocompromised patient. Ann Pathol 2004, 24:187-191
7. Huffnagle GB, Chen GH, Curtis JL, McDonald RA, Strieter RM, Toews GB: Down-regulation of the afferent phase of T cell-mediated pulmonary inflammation and immunity by a high melanin-producing strain of Cryptococcus neoformans. J Immunol 1995, 155:3507-3516
8. Osterholzer JJ, Surana R, Milam JE, Montano GT, Chen GH, Sonstein J, Curtis JL, Huffnagle GB, Toews GB, Olszewski MA: Cryptococcal urease promotes the accumulation of immature dendritic cells and a non-protective T2 immune response within the lung. Am J Pathol 2009, 174:932-943
9. Chretien F, Lortholary O, Kansau I, Neuville S, Gray F, Dromer F: Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia. J Infect Dis 2002, 186:522-530
10. Lortholary O, Improvisi L, Nicolas M, Provost F, Dupont B, Dromer F: Fungemia during murine cryptococcosis sheds some light on pathophysiology. Med Mycol 1999, 37:169-174
11. Olszewski MA, Huffnagle GB, Traynor TR, McDonald RA, Cook DN, Toews GB: Regulatory effects of macrophage inflammatory protein 1alpha/CCL3 on the development of immunity to Cryptococcus neoformans depend on expression of early inflammatory cytokines. Infect Immun 2001, 69:6256-6263
12. Blackstock R, Buchanan KL, Adesina AM, Murphy JW: Differential regulation of immune responses by highly and weakly virulent Cryptococcus neoformans isolates. Infect Immun 1999, 67:3601-3609
13. Olszewski MA, Noverr MC, Chen GH, Toews GB, Cox GM, Perfect JR, Huffnagle GB: Urease expression by Cryptococcus neoformans promotes microvascular sequestration, thereby enhancing central nervous system invasion. Am J Pathol 2004, 164:1761-1771
14. Blanco JL, Garcia ME: Immune response to fungal infections. Vet Immunol Immunopathol 2008, 125:47-70
15. Ma H, May RC: Virulence in Cryptococcus species. Adv Appl Microbiol 2009, 67:131-190
16. Traynor TR, Kuziel WA, Toews GB, Huffnagle GB: CCR2 expression determines T1 versus T2 polarization during pulmonary Cryptococcus neoformans infection. J Immunol 2000, 164:2021-2027
17. Arora S, Hernandez Y, Erb-Downward JR, McDonald RA, Toews GB, Huffnagle GB: Role of IFN-gamma in regulating T2 immunity and the development of alternatively activated macrophages during allergic bronchopulmonary mycosis. J Immunol 2005, 174:6346-6356
18. Kleinschek MA, Muller U, Brodie SJ, Stenzel W, Kohler G, Blumenschein WM, Straubinger RK, McClanahan T, Kastelein RA, Alber G: IL-23 enhances the inflammatory cell response in Cryptococcus neoformans infection and induces a cytokine pattern distinct from IL-12. J Immunol 2006, 176:1098-1106
19. Muller U, Stenzel W, Kohler G, Werner C, Polte T, Hansen G, Schutze N, Straubinger RK, Blessing M, McKenzie AN, Brombacher F, Alber G: IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans. J Immunol 2007, 179:5367-5377
20. Huffnagle GB, Lipscomb MF, Lovchik JA, Hoag KA, Street NE: The role of CD4+ and CD8+ T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J Leukoc Biol 1994, 55:35-42
21. Herring AC, Falkowski NR, Chen GH, McDonald RA, Toews GB, Huffnagle GB: Transient neutralization of tumor necrosis factor alpha can produce a chronic fungal infection in an immunocompetent host: potential role of immature dendritic cells. Infect Immun 2005, 73:39-49
22. Chen GH, McDonald RA, Wells JC, Huffnagle GB, Lukacs NW, Toews GB: The gamma interferon receptor is required for the protective pulmonary inflammatory response to Cryptococcus neoformans. Infect Immun 2005, 73:1788-1796
23. Hernandez Y, Arora S, Erb-Downward JR, McDonald RA, Toews GB, Huffnagle GB: Distinct roles for IL-4 and IL-10 in regulating T2 immunity during allergic bronchopulmonary mycosis. J Immunol 2005, 174:1027-1036
24. Mowen KA, Glimcher LH: Signaling pathways in Th2 development. Immunol Rev 2004, 202:203-222
25. Blackstock R, Buchanan KL, Cherniak R, Mitchell TG, Wong B, Bartiss A, Jackson L, Murphy JW: Pathogenesis of Cryptococcus neoformans is associated with quantitative differences in multiple virulence factors. Mycopathologia 1999, 147:1-11
26. Chen GH, McNamara DA, Hernandez Y, Huffnagle GB, Toews GB, Olszewski MA: Inheritance of immune polarization patterns is linked to resistance versus susceptibility to Cryptococcus neoformans in a mouse model. Infect Immun 2008, 76:2379-2391
27. Kawakami K, Hossain Qureshi M, Zhang T, Koguchi Y, Xie Q, Kurimoto M, Saito A: Interleukin-4 weakens host resistance to pulmonary and disseminated cryptococcal infection caused by combined treatment with interferon-gamma- inducing cytokines. Cell Immunol 1999, 197:55-61
28. Muller U, Stenzel W, Kohler G, Polte T, Blessing M, Mann A, Piehler D, Brombacher F, Alber G: A gene-dosage effect for interleukin-4 receptor alpha-chain expression has an impact on Th2-mediated allergic inflammation during bronchopulmonary mycosis. J Infect Dis 2008, 198:1714-1721
29. Olszewski MA, Huffnagle GB, McDonald RA, Lindell DM, Moore BB, Cook DN, Toews GB: The role of macrophage inflammatory protein-1alpha/CCL3 in regulation of T cell-mediated immunity to Cryptococcus neoformans infection. J Immunol 2000, 165:6429-6436
30. Stenzel W, Muller U, Kohler G, Heppner FL, Blessing M, McKenzie AN, Brombacher F, Alber G: IL-4/IL-13-dependent alternative activation of macrophages but not microglial cells is associated with uncontrolled cerebral cryptococcosis. Am J Pathol 2009, 174:486-496
31. Cox GM, Mukherjee J, Cole GT, Casadevall A, Perfect JR: Urease as a virulence factor in experimental cryptococcosis. Infect Immun 2000, 68:443-448
32. Noverr MC, Cox GM, Perfect JR, Huffnagle GB: Role of PLB1 in pulmonary inflammation and cryptococcal eicosanoid production. Infect Immun 2003, 71:1538-1547
33. Wormley FL Jr, Perfect JR, Steele C, Cox GM: Protection against cryptococcosis by using a murine gamma interferon-producing Cryptococcus neoformans strain. Infect Immun 2007, 75:1453-1462
34. McKenzie GJ, Fallon PG, Emson CL, Grencis RK, McKenzie AN: Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses. J Exp Med 1999, 189:1565-1572
35. Huffnagle GB, Boyd MB, Street NE, Lipscomb MF: IL-5 is required for eosinophil recruitment, crystal deposition, and mononuclear cell recruitment during a pulmonary Cryptococcus neoformans infection in genetically susceptible mice (C57BL/6). J Immunol 1998, 160:2393-2400
36. Osterholzer JJ, Curtis JL, Polak T, Ames T, Chen GH, McDonald R, Huffnagle GB, Toews GB: CCR2 mediates conventional dendritic cell recruitment and the formation of bronchovascular mononuclear cell infiltrates in the lungs of mice infected with Cryptococcus neoformans. J Immunol 2008, 181:610-620
37. Blackstock R, Murphy JW: Role of interleukin-4 in resistance to Cryptococcus neoformans infection. Am J Respir Cell Mol Biol 2004, 30:109-117
38. Happel KI, Zheng M, Young E, Quinton LJ, Lockhart E, Ramsay AJ, Shellito JE, Schurr JR, Bagby GJ, Nelson S, Kolls JK: Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J Immunol 2003, 170:4432-4436
39. Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P, Oliver P, Huang W, Zhang P, Zhang J, Shellito JE, Bagby GJ, Nelson S, Charrier K, Peschon JJ, Kolls JK: Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 2001, 194:519-527
40. Lindell DM, Moore TA, McDonald RA, Toews GB, Huffnagle GB: Generation of antifungal effector CD8+ T cells in the absence of CD4+ T cells during Cryptococcus neoformans infection. J Immunol 2005, 174:7920-7928
41. Ferretti S, Bonneau O, Dubois GR, Jones CE, Trifilieff A: IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: iL-15 as a possible trigger. J Immunol 2003, 170:2106-2112
42. Granger DL, Perfect JR, Durack DT: Macrophage-mediated fungistasis in vitro: requirements for intracellular and extracellular cytotoxicity. J Immunol 1986, 136:672-680
43. Lovchik JA, Lyons CR, Lipscomb MF: A role for gamma interferoninduced nitric oxide in pulmonary clearance of Cryptococcus neoformans. Am J Respir Cell Mol Biol 1995, 13:116-124
44. Vecchiarelli A, Pietrella D, Dottorini M, Monari C, Retini C, Todisco T, Bistoni F: Encapsulation of Cryptococcus neoformans regulates fungicidal activity and the antigen presentation process in human alveolar macrophages. Clin Exp Immunol 1994, 98:217-223
45. Huffnagle GB, Strieter RM, McNeil LK, McDonald RA, Burdick MD, Kunkel SL, Toews GB: Macrophage inflammatory protein-1alpha (MIP-1alpha) is required for the efferent phase of pulmonary cellmediated immunity to a Cryptococcus neoformans infection. J Immunol 1997, 159:318-327
46. Lindell DM, Ballinger MN, McDonald RA, Toews GB, Huffnagle GB: Diversity of the T-cell response to pulmonary Cryptococcus neoformans infection. Infect Immun 2006, 74:4538-4548
47. Charlier C, Nielsen K, Daou S, Brigitte M, Chretien F, Dromer F: Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans. Infect Immun 2009, 77:120-127